Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin.

PubWeight™: 1.23‹?› | Rank: Top 10%

🔗 View Article (PMID 11350766)

Published in Am J Physiol Endocrinol Metab on June 01, 2001

Authors

G Booth1, T J Stalker, A M Lefer, R Scalia

Author Affiliations

1: Department of Physiology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.

Articles citing this

Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice. Cell Metab (2010) 2.09

Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo. J Clin Invest (2007) 2.03

Importance of perioperative glycemic control in general surgery: a report from the Surgical Care and Outcomes Assessment Program. Ann Surg (2013) 1.93

Microvascular responses to cardiovascular risk factors. Microcirculation (2010) 1.30

Insulin-treated diabetes is not associated with increased mortality in critically ill patients. Crit Care (2010) 1.18

Diabetes and atherosclerosis: is there a role for hyperglycemia? J Lipid Res (2008) 1.09

Inflammation determines the pro-adhesive properties of high extracellular d-glucose in human endothelial cells in vitro and rat microvessels in vivo. PLoS One (2010) 1.06

Is insulin an endogenous cardioprotector? Crit Care (2002) 0.94

Variation in characteristics of islets of Langerhans in insulin-resistant, diabetic and non-diabetic-rat strains. Int J Exp Pathol (2010) 0.93

Increase in GLUT1 in smooth muscle alters vascular contractility and increases inflammation in response to vascular injury. Arterioscler Thromb Vasc Biol (2010) 0.92

Protein kinase C upregulates intercellular adhesion molecule-1 and leukocyte-endothelium interactions in hyperglycemia via activation of endothelial expressed calpain. Arterioscler Thromb Vasc Biol (2010) 0.92

Poly(ADP-ribose) polymerase-1 inhibition in brain endothelium protects the blood-brain barrier under physiologic and neuroinflammatory conditions. J Cereb Blood Flow Metab (2014) 0.90

Endothelial dysfunction in mice with streptozotocin-induced type 1 diabetes is opposed by compensatory overexpression of cyclooxygenase-2 in the vasculature. Endocrinology (2008) 0.90

Impact of diabetes on long-term outcome after primary angioplasty: insights from the DESERT cooperation. Diabetes Care (2012) 0.88

The mannose-binding lectin pathway is a significant contributor to reperfusion injury in the type 2 diabetic heart. Diab Vasc Dis Res (2009) 0.86

CXCL1-triggered interaction of LFA1 and ICAM1 control glucose-induced leukocyte recruitment during inflammation in vivo. Mediators Inflamm (2012) 0.85

Insulin and the critically ill. Crit Care (2002) 0.82

Diabetic vascular disease and the potential role of macrophage glucose metabolism. Ann Med (2011) 0.82

2013 Russell Ross memorial lecture in vascular biology: cellular and molecular mechanisms of diabetes mellitus-accelerated atherosclerosis. Arterioscler Thromb Vasc Biol (2014) 0.81

A novel function of insulin in rat dermis. J Physiol (2004) 0.81

Effects of glycemic regulation on chronic postischemia pain. Anesthesiology (2011) 0.77

1H-NMR-based metabolomic analysis of cerebrospinal fluid from adult bilateral moyamoya disease: comparison with unilateral moyamoya disease and atherosclerotic stenosis. Medicine (Baltimore) (2015) 0.76

Simple clinical risk score for no-reflow prediction in patients undergoing primary Percutaneous Coronary Intervention with acute STEMI. Pak J Med Sci (2015) 0.75

Potential beneficial mechanisms of insulin (glucose-potassium) in acute myocardial infarction. Neth Heart J (2005) 0.75

Inhaled aerosolized insulin ameliorates hyperglycemia-induced inflammatory responses in the lungs in an experimental model of acute lung injury. Crit Care (2013) 0.75

Articles by these authors

Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion. Circulation (1995) 2.08

Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology (1994) 2.07

Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci U S A (1995) 1.98

In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest (1993) 1.80

Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice. Am J Physiol (1999) 1.72

Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res (1993) 1.63

Prostacyclin: a potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia. Science (1978) 1.62

Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts. Circulation (1999) 1.62

Thromboxane release during pacing-induced angina pectoris: possible vasoconstrictor influence on the coronary vasculature. Circulation (1980) 1.56

Activated neutrophils aggravate endothelial dysfunction after reperfusion of the ischemic feline myocardium. Am Heart J (1992) 1.53

Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2. Proc Natl Acad Sci U S A (1980) 1.52

Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion. J Clin Invest (1991) 1.48

Studies on the protective effect of prostacyclin in acute myocardial ischemia. Eur J Pharmacol (1979) 1.47

Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation. Proc Natl Acad Sci U S A (1979) 1.47

Platelet-targeting sensor reveals thrombin gradients within blood clots forming in microfluidic assays and in mouse. J Thromb Haemost (2012) 1.43

Protective action of methylprednisolone on the myocardium during experimental myocardial ischemia in the cat. Circ Res (1974) 1.40

Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation (1992) 1.40

Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats. Arterioscler Thromb Vasc Biol (1999) 1.39

Lipoxin A4 stable analogs inhibit leukocyte rolling and adherence in the rat mesenteric microvasculature: role of P-selectin. Proc Natl Acad Sci U S A (1997) 1.38

Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock. Am J Physiol (1990) 1.37

Simvastatin exerts both anti-inflammatory and cardioprotective effects in apolipoprotein E-deficient mice. Circulation (2001) 1.34

Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit Care Med (1991) 1.33

Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation (1990) 1.31

Presence of a myocardial depressant factor in patients in circulatory shock. Surgery (1971) 1.28

The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation (1992) 1.28

Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion. J Pharmacol Exp Ther (1990) 1.26

Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J Clin Invest (1997) 1.24

Cardiovascular effects of acute hypercholesterolemia in rabbits. Reversal with lovastatin treatment. J Clin Invest (1989) 1.24

Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J Pharmacol Exp Ther (1992) 1.22

Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. Am J Physiol (1994) 1.21

Lack of endothelium-dependent relaxation in coronary resistance arteries of cholesterol-fed rabbits. Am J Physiol (1989) 1.21

Regulating thrombus growth and stability to achieve an optimal response to injury. J Thromb Haemost (2011) 1.20

Blood-borne humoral factors in the pathophysiology of circulatory shock. Circ Res (1973) 1.18

Time course of coronary vascular endothelial adhesion molecule expression during reperfusion of the ischemic feline myocardium. J Leukoc Biol (1995) 1.16

Leukocyte-endothelium interaction during the early stages of hypercholesterolemia in the rabbit: role of P-selectin, ICAM-1, and VCAM-1. Arterioscler Thromb Vasc Biol (1998) 1.15

Monoclonal antibody to L-selectin attenuates neutrophil accumulation and protects ischemic reperfused cat myocardium. Circulation (1993) 1.13

A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid. Br J Pharmacol (2001) 1.13

Nitric oxide protects against leukocyte-endothelium interactions in the early stages of hypercholesterolemia. Arterioscler Thromb Vasc Biol (1995) 1.12

Role of a myocardial depressant factor in the pathogenesis of circulatory shock. Fed Proc (1971) 1.11

Anti-EDRF effect of tumor necrosis factor in isolated, perfused cat carotid arteries. Am J Physiol (1989) 1.11

Antibodies which antagonise the effects of prostacyclin. Nature (1978) 1.10

Myocardial ischemia/reperfusion injury in NADPH oxidase-deficient mice. Circ Res (2000) 1.10

Origin of myocardial depressant factor in shock. Am J Physiol (1970) 1.09

Mechanisms of vascular preservation by a novel NO donor following rat carotid artery intimal injury. Am J Physiol (1995) 1.08

Relationship between splanchnic blood flow and a myocardial depressant factor in endotoxin shock. Surgery (1971) 1.08

Mechanism of the cardioprotective effect of transforming growth factor beta 1 in feline myocardial ischemia and reperfusion. Proc Natl Acad Sci U S A (1993) 1.08

Cardioprotective effects of a novel proteasome inhibitor following ischemia and reperfusion in the isolated perfused rat heart. J Mol Cell Cardiol (1999) 1.08

Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease. Cardiovasc Res (2001) 1.06

C-peptide inhibits leukocyte-endothelium interaction in the microcirculation during acute endothelial dysfunction. FASEB J (2000) 1.05

Direct measurement of nitric oxide release from vascular endothelial cells. J Appl Physiol (1985) (1996) 1.05

Role of lysosomes in the pathogenesis of splanchnic ischemia shock in cats. Circ Res (1970) 1.05

Peroxynitrite reduces myocardial infarct size and preserves coronary endothelium after ischemia and reperfusion in cats. Circulation (1997) 1.04

Role of platelet activating factor in propagation of cardiac damage during myocardial ischemia. J Pharmacol Exp Ther (1988) 1.04

Pathophysiological mechanisms of sudden death induced by platelet activating factor. Br J Pharmacol (1984) 1.04

Essential role of P-selectin in the initiation of the inflammatory response induced by hemorrhage and reinfusion. J Exp Med (1999) 1.03

Nitric oxide: nature's naturally occurring leukocyte inhibitor. Circulation (1997) 1.03

Responsiveness of platelets and coronary arteries from different species to synthetic thromboxane and prostaglandin endoperoxide analogues. Br J Pharmacol (1983) 1.03

Blockade of platelet endothelial cell adhesion molecule-1 protects against myocardial ischemia and reperfusion injury in cats. J Immunol (1996) 1.02

Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells. Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors. Circ Res (1996) 1.02

Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle. Circ Res (1994) 1.02

Cytoprotective actions of prostacyclin during hypoxia in the isolated perfused cat liver. Am J Physiol (1980) 1.02

Rapid restoration of normal endothelial functions in genetically hyperlipidemic mice by a synthetic mediator of reverse lipid transport. Arterioscler Thromb Vasc Biol (2000) 1.01

Beneficial effects of SPM-5185, a cysteine-containing NO donor in myocardial ischemia-reperfusion. Am J Physiol (1992) 1.01

Role of platelet-activating factor-acether in mediating guinea pig anaphylaxis. Science (1986) 1.01

Relationship of plasma peptides to the myocardial depressant factor in hemorrhagic shock in cats. Circ Res (1970) 1.00

Time course and mechanism of endothelial dysfunction in isolated ischemic- and hypoxic-perfused rat hearts. Am J Physiol (1990) 1.00

Recombinant soluble P-selectin glycoprotein ligand-1 protects against myocardial ischemic reperfusion injury in cats. Cardiovasc Res (1999) 0.99

Role of prostacyclin in the preservation of ischemic myocardial tissue in the perfused cat heart. Circ Res (1980) 0.98

Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion: role of selectins. Circulation (1998) 0.98

Actions of prostaglandins on isolated perfused cat coronary arteries. Am J Physiol (1978) 0.98

Protection from myocardial reperfusion injury by acute administration of 17 beta-estradiol. J Mol Cell Cardiol (1996) 0.98

Anti-shock effects of human superoxide dismutase in splanchnic artery occlusion (SAO) shock. Proc Soc Exp Biol Med (1988) 0.97

Neutrophil-mediated vasoconstriction and endothelial dysfunction in low-flow perfusion-reperfused cat coronary artery. Circ Res (1991) 0.97

HMG-CoA reductase inhibition protects the diabetic myocardium from ischemia-reperfusion injury. FASEB J (2001) 0.96

Antishock and endothelial protective actions of a NO donor in mesenteric ischemia and reperfusion. Circ Shock (1992) 0.96

Role of nitric oxide in the regulation of acute and chronic inflammation. Antioxid Redox Signal (2000) 0.96

Characterization of a myocardial depressant factor present in hemorrhagic shock. Am J Physiol (1967) 0.96

Regulation of P-selectin expression in human endothelial cells by nitric oxide. Am J Physiol (1997) 0.96

Homocysteine provokes leukocyte-endothelium interaction by downregulation of nitric oxide. Gen Pharmacol (1999) 0.96

Leukotrienes as mediators of ischemia and shock. Biochem Pharmacol (1986) 0.96

Plasma activation during splanchnic arterial occlusion shock. Shock (2000) 0.95

PR-39, a potent neutrophil inhibitor, attenuates myocardial ischemia-reperfusion injury in mice. Am J Physiol Heart Circ Physiol (2000) 0.95

Eicosanoids as mediators of ischemia and shock. Fed Proc (1985) 0.95

Mechanisms of production of circulatory shock factors in isolated perfused pancreas. Am J Physiol (1972) 0.95

Prostacyclin mediation of vasodilation following mesenteric traction. Anesthesiology (1988) 0.94

Mechanisms of cardioprotection by peroxynitrite in myocardial ischemia and reperfusion injury. Am J Physiol (1998) 0.94

Mechanism of protection against arachidonate induced sudden death by glucocorticoid. Prostaglandins (1981) 0.94